Erik Imel
Director of Musculoskeletal, Informatics and Methodological Core · Indiana Center for Musculoskeletal Health
Credentials: · · · · ·
History
- Present
Informatics and Methodological Core · Indiana Center for Musculoskeletal Health
- 2007–2008
Indiana University School of Medicine and Riley Hospital for Children
Research
A clinician's guide to X-linked hypophosphatemia
Review · Journal of Bone and Mineral Research · 2011 · 461 citations
Biochemical and Biophysical Research Communications · 2010 · 432 citations
Burosumab Therapy in Children with X-Linked Hypophosphatemia
New England Journal of Medicine · 2018 · 380 citations
35 papers · 4 as a resident
34 papers
21 papers
16 papers
11 papers
11 papers
11 papers
9 papers
Grants
- 2017–2027
Indiana Core Center for Clinical Research in Musculoskeletal Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases · P30
Project lead · $1M · Indiana University Indianapolis
- 2020–2024
Sarcopenia: Computable Phenotypes and Clinical Outcomes.
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $576.8K · Indiana University Indianapolis
- 2009–2015
FGF23 in Pediatric Phosphate Physiology and X-Linked Hypophosphatemic Rickets.
National Institute of Arthritis and Musculoskeletal and Skin Diseases · K23
Contact PI · $642.1K · Indiana University Indianapolis
Clinical trials
- 2019–2027
CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis
Principal investigator · Active not recruiting
Indiana University
- 2019–2021
Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders
Principal investigator · Withdrawn · Phase 1, Phase 2
Indiana University
- 2024–2029
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
Site PI · Recruiting · Phase 1, Phase 2
Kyowa Kirin Co., Ltd.